N6-(6-Amino)hexyl-dATP - ATTO-565
|
|
|
N1-Benzoylpseudouridine
|
|
|
5-Propargylamino-dCTP - 5-FAM
|
|
|
EDA-ADP
|
|
|
5-Propargylamino-CTP - ATTO-620
|
|
|
γ-(6-Aminohexyl)-ATP - MANT
|
|
|
EDA-m7GTP - ATTO-Rho11
|
|
|
γ-(6-Aminohexyl)-ATP - ATTO-647N
|
|
|
Azide-PEG4-aminoallyl-dUTP
|
|
|
EDA-ADP - ATTO-Rho12
|
|
|
4-N3-PET-8-Biotin-11-cGMP
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - ATTO-540Q
|
|
|
Adenosine 2-amidine hydrochloride
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - 5-FAM
|
|
|
CMP - lyophilized
|
|
|
(±)-2-Aminobutan-1-ol 2-chlorotrityl resin
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - DY-776
|
|
|
2-Amino-2'-deoxy-N6-ethyl-adenosine
|
|
|
EDA-m7GTP - ATTO-495
|
|
|
6-Amino-4-hydroxyamino-1-(2-deoxy-b-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
|
|
|
3,5'-Bis(O-t-butyldimethylsilyl)-2'-O-methyl-5-methylcytidine
|
|
|
8-[(6-Amino)hexyl]-amino-GTP - ATTO-Rho11
|
|
|
EDA-GTPγS - ATTO-Rho13
|
|
|
5-Methyl-dCDP
|
|
|
dGTP solution - Lithium Salt
|
|
|
EDA-ATP - ATTO-488
|
|
|
EDA-AppNHp (EDA-AMPPNP) - ATTO-390
|
|
|
EDA-AppNHp (EDA-AMPPNP) - ATTO-633
|
|
|
7-Propargylamino-7-deaza-ddGTP - ATTO-540Q
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - ATTO-655
|
|
|
EDA-AppNHp (EDA-AMPPNP) - ATTO-680
|
|
|
EDA-AppNHp (EDA-AMPPNP) - ATTO-655
|
|
|
EDA-ATPγS - MANT
|
|
|
γ-(6-Aminohexyl)-ATP - ATTO-532
|
|
|
8-[(6-Amino)hexyl]-amino-GMP - ATTO-612Q
|
|
|
EDA-XTP
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - ATTO-580Q
|
|
|
5-Propargylamino-ddCTP - ATTO-594
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - ATTO-Rho12
|
|
|
EDA-AppNHp (EDA-AMPPNP) - 6-ROX
|
|
|
N6-(6-Amino)hexyl-ATP - ATTO-740
|
|
|
EDA-6-Thio-GMP
|
|
|
Biotin-18-dCTP
|
|
|
EDA-ADP - ATTO-580Q
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - 5/6-TAMRA
|
|
|
pCp-Cy5
|
|
|
EDA-GTPγS - Texas Red
|
|
|
γ-(6-Aminohexyl)-dATP - ATTO-488
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - 5/6-TAMRA
|
|
|
EDA-m7GDP - ATTO-612Q
|
|
|
5-Propargylamino-dCTP - 6-ROX
|
|
|
γ-[(6-Aminohexyl)imido]-ATP - 5-FAM
|
|
|
γ-[(6-Aminohexyl)-imido]-dTTP
|
|
|
7-Propargylamino-7-deaza-dATP - ATTO-580Q
|
|
|
EDA-AppNHp (EDA-AMPPNP) - ATTO-620
|
|
|
Guanosine (N-PAC)
|
|
|
7-Propargylamino-7-deaza-dATP - OYSTER-656
|
|
|
EDA-GTP - BDP-FL
|
|
|
5-Propargylamino-ddCTP - ATTO-425
|
|
|
Sp-6-AE-cAMPS-Agarose
|
|
|
EDA-ATPγS - ATTO-580Q
|
|
|
EDA-m7GDP - ATTO-425
|
|
|
5-Propargylamino-CTP - ATTO-594
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - ATTO-Rho101
|
|
|
UDPβS
|
|
|
5-Propargylamino-CTP - ATTO-Rho6G
|
|
|
EDA-ATPγS - 5/6-TAMRA
|
|
|
Mant-N6-Methyl-ATP
|
|
|
6-Amino-4-methoxy-1-(2,3,5-tri-O-benzoyl-b-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
|
|
|
5-Propargylamino-CTP - 5/6-TAMRA
|
|
|
8-[(6-Amino)hexyl]-amino-GTP - ATTO-550
|
|
|
EDA-ATPγS - ATTO-665
|
|
|
Mant-XDP
|
|
|
8-[(6-Amino)hexyl]-amino-ATP - ATTO-550
|
|
|
8-[(6-Amino)hexyl]-amino-GMP - DY-776
|
|
|
2-Iodo-ATPγS
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - ATTO-Rho101
|
|
|
Sp-8-Br-cAMPS-AM
|
|
|
5-Propargylamino-dCTP - ATTO-390
|
|
|
7-Propargylamino-7-deaza-ddGTP - 5-FAM
|
|
|
7-Propargylamino-7-deaza-ddATP - Cy3
|
|
|
5-AcOHg-dCTP
|
|
|
γ-[(6-Aminohexyl)imido]-ATP - ATTO-532
|
|
|
3'-Deoxy-3'-fluoro-N6-ethyladenosine
|
|
|
TP2(Nic)
|
|
|
dNTP Mix incl. dUTP / 10 mM
|
|
|
Dermatan Sulfate (dp8)
|
|
|
EDA-GTP - ATTO-Rho6G
|
|
|
EDA-ADP - ATTO-665
|
|
|
EDA-ADP - ATTO-425
|
|
|
3'-Deoxy-N1-Methylinosine
|
|
|
EDA-GTP - ATTO-532
|
|
|
8-[Fluo]-cGMP
|
|
|
8-Biotin-11-cAMP
|
|
|
Sp-c-diAMPS
|
|
|
EDA-GTP - 5/6-TAMRA
|
|
|
N1-Methyl xylo-guanosine
|
|
|
EDA-m7GDP - 6-JOE
|
|
|
5-Propargylamino-ddCTP - ATTO-633
|
|
|
γ-[(6-Azidohexyl)-imido]-ATP
|
|
|